Peter R. Mazal
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
B7-H3 (CD276) as a candidate therapeutic target in medullary thyroid cancer.
Journal: Endocrine-related cancer
Published: May 06, 2026
Prognostic Value of 18F-FDG and 18F-FEC Uptake in Hepatocellular Carcinoma Using Contrast-Enhanced Integrated PET/MRI: Correlation with Histology and Survival.
Journal: Cancers
Published: April 06, 2026
PSMA-Directed PET/MRI Enables Noninvasive Diagnosis and Prognosis in Patients with Increased PSA Levels: Results from the Prospective Randomized RAPID Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 20, 2025
Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratios.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 06, 2025
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung.
Journal: Endocrine pathology
Published: January 14, 2025
Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center.
Journal: Journal of cancer research and clinical oncology
Published: December 21, 2024
Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 24, 2024
Liver metastases in high-grade neuroendocrine neoplasms: A comparative study of hepatic tumor volume and biochemical findings in NET G3 versus NEC.
Journal: Journal of neuroendocrinology
Published: May 23, 2024
Metastatic disease and major adverse cardiovascular events preceding diagnosis are the main determinants of disease-specific survival of pheochromocytoma/paraganglioma: long-term follow-up of 303 patients.
Journal: Frontiers in endocrinology
Published: April 17, 2024
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.
Journal: Therapeutic advances in medical oncology
Published: August 31, 2023
Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Journal: Virchows Archiv : an international journal of pathology
Published: August 18, 2023
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.
Journal: Endocrine-related cancer
Published: May 24, 2023
Last Updated: 09/26/2026